ETFs Amgen Inc.

AMGN

US0311621009

Name	Varia. Jan 1.	Weight	AuM
NOMURA NEXT FUNDS DOW JONES INDUSTRIAL AVERAGE ETF - JPY	+0.29%	5.08%	136 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	-0.48%	3.71%	26 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY ETF - CAD	0.00%	3.24%	1 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	-.--%	1.65%	4 M€
VICTORYSHARES US EQ INCOME ENHANCED VOLATILITY WTD ETF - USD	+11.60%	1.55%	615 M€
LEVERAGE SHARES -5X SHORT NASDAQ 100 ETP - USD	+6.97%	1.29%	5 M€
LEVERAGE SHARES PUBLIC LIMITED COMPANY - 3X LONG US TECH 100 ETP	-.--%	1.29%	2 M€
LEVERAGE SHARES 5X LONG NASDAQ 100 ETP - USD	0.00%	1.19%	29 M€
DIREXION NASDAQ-100 EQUAL WEIGHTED ETF - USD	+0.36%	1.04%	1,034 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	-.--%	0.88%	2 M€
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD	+3.32%	0.77%	711 M€

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.4% of net sales.

Employees

28,000

Sector

Pharmaceuticals

Calendar

Apr. 28 - Q1 2026 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

369.19USD

Average target price

345.56USD

Spread / Average Target

-6.40%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
369.19 ^USD	+1.52%		-3.94%	+12.80%

Feb. 12	Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM
Feb. 12	European Commission approves Amgen's Uplizna® for generalized myasthenia gravis	RE